Clinical Trials
309 trialsTRIDENT-1
Turning Point Therapeutics, Inc.
Smoking Cessation Treatment for Head & Neck Cancer Patients
M.D. Anderson Cancer Center
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
GlaxoSmithKline
PIKALO-1
Eli Lilly and Company
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
Pfizer
Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
University of Arizona
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
M.D. Anderson Cancer Center
THYSU
University Hospital, Bordeaux
OP-NEU-101
Onchilles Pharma Inc
A Study of DEG6498 in Participants With Solid Tumors
Degron Therapeutics Co.
Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors
Medical University of South Carolina
EGRET
AstraZeneca
Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma
Vanderbilt-Ingram Cancer Center
A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
Cancer Research UK
A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers
Pfizer
High-Resolution PET-CT Imaging for Surgical Margin Visualization
Vanderbilt-Ingram Cancer Center
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
CABOTHYROID
Grupo Espanol de Tumores Neuroendocrinos
CHEMOVES
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
NAVIGATE
Bayer
ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer
The First Affiliated Hospital of Xiamen University
LIBRETTO-001
Eli Lilly and Company
RAISE
Children's Hospital of Philadelphia
ReRT
The New York Proton Center
Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
FLAGSHP-1
Erasca, Inc.
Study of CHS-114 in Participants With Advanced Solid Tumors
Coherus Oncology, Inc.
Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
NBI-CAB
Centre Oscar Lambret
MK-4700-001
Merck Sharp & Dohme LLC
Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life
M.D. Anderson Cancer Center
AcceleRET-Lung
Hoffmann-La Roche
EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study
Università Cattolica di Milano
IDOV-Immune for Advanced Solid Tumors
ViroMissile, Inc.
PORTICO
Luzerner Kantonsspital
DETERMINE
Cancer Research UK
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Sichuan Enray Pharmaceutical Sciences Company
A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.
Pfizer
ONE TEAM
Duke University
Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
UNC Lineberger Comprehensive Cancer Center
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Tizona Therapeutics, Inc
Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors
Dana-Farber Cancer Institute
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
University of California, San Diego
MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers
Adaptimmune
Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck
University of California, San Diego
EMITT-1
Grey Wolf Therapeutics
Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients
Georgetown University
Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients
University of California, Davis
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors
AbbVie